CANCER BIOSTATISTICS SHARED RESOURCE ABSTRACT The Cancer Biostatistics (CB) Shared Resource provides state-of-the-art biostatistics and research design support to laboratory, translational, clinical, and population sciences investigators at Huntsman Cancer Institute (HCI). It is a section of the University of Utah (U of U) Study Design and Biostatistics Center (SDBC), the biostatistics core of the U of U Health Sciences Center and its National Institutes of Health Clinical and Translational Science Award-supported Center for Clinical and Translational Science (CCTS). The CB Shared Resource is led by Kenneth Boucher, PhD, an accomplished biostatistician and a Cancer Center member since 1996, and includes five personnel with specialized cancer research expertise. Dr. Boucher works in close coordination with Tom Greene, PhD, SDBC Director, a senior biostatistician with more than 25 years of experience serving as the lead statistician for NIH- and industry-sponsored multi-center clinical trials and other large-scale multidisciplinary research efforts. The CB Shared Resource arranges statistical teams to support all stages of the research process to benefit Cancer Center members, providing HCI researchers with integrated statistical and epidemiologic expertise in study design, health measurement, and data analysis. This expertise includes clinical trial and observational study design, longitudinal data analysis, linear and nonlinear mixed effects models, survival analysis, multivariate methods, meta-analysis, Bayesian models, computational statistics, diagnostic testing, comparative effectiveness research, modern causal inference, survey design and questionnaire development, item response theory and computer adaptive testing, and statistical genetics and genomics. In addition to providing statistical analyses, the CB Shared Resource provides guidance in formulation of research objectives, development of informative and efficient study designs, implementation of randomized procedures, design and implementation of surveys, selection of appropriate instruments and development of new instruments for measurement of health outcomes, development of appropriate procedures for collection and secure storage of data, collaborative formulation of pre-specified analysis plans prior to data analysis, and interpretation and presentation of data in publications and oral presentations. The CB Shared Resource is located in the HCI building, providing direct on-site access to resource users throughout all stages of the research process. The importance of the CB Shared Resource is demonstrated by its wide array of users and its contributions to numerous publications, many in high-profile journals. In 2013, use of the CB Shared Resource by Cancer Center investigators with peer-reviewed funding exceeded 66%, while the CCSG budget request is only 6% ($46,388) of the total proposed budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-29
Application #
9478883
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
29
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yazdimamaghani, Mostafa; Moos, Philip J; Ghandehari, Hamidreza (2018) Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles. Nanomedicine 14:533-545
Vahrenkamp, Jeffery M; Yang, Chieh-Hsiang; Rodriguez, Adriana C et al. (2018) Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor ? In Endometrial Cancer. Cell Rep 22:2995-3005
Gupta, Sumati; Albertson, Daniel; Gaston, David et al. (2018) Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System. Clin Genitourin Cancer 16:e373-e382
Flack, Caralyn E; Parkinson, John S (2018) A zipped-helix cap potentiates HAMP domain control of chemoreceptor signaling. Proc Natl Acad Sci U S A 115:E3519-E3528
Al-Agha, Abdulmoein Eid; Ahmed, Ihab Abdulhamed; Nuebel, Esther et al. (2018) Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation. J Clin Endocrinol Metab 103:555-563
Petersen, Jenna; Koptiuch, Cathryn; Wu, Yelena P et al. (2018) Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis. Patient Educ Couns 101:2011-2017
Wu, Yelena P; Aspinwall, Lisa G; Nagelhout, Elizabeth et al. (2018) Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma. J Cancer Educ 33:774-781
Pishas, Kathleen I; Drenberg, Christina D; Taslim, Cenny et al. (2018) Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. Mol Cancer Ther 17:1902-1916
Blackburn, Brenna E; Ganz, Patricia A; Rowe, Kerry et al. (2018) Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv 12:702-711
Ye, Zhizhou; Ayer, Donald E (2018) Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation. Mol Cell Biol :

Showing the most recent 10 out of 1193 publications